GENERATE:BIOMEDICINES
Live / Applied — Suspended — suspension check completed, case still suspended (as of 08 Jan 2026)
What this means for you
Not registered yet, but its 02 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98113071
- Mark type
- Stylized text
- Filed
- 02 Aug 2023
- Attorney of record
- Jennifer M. Mikulina
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical therapeutic preparations, pharmaceutical preparations, medical therapeutics in the nature of pharmaceutical preparations, therapeutic vaccines, and prophylactic vaccines, and medical pharmaceutical preparations in the fields of oncology, infectious disease, virology, cardiology, allergy, immunology, rheumatology, endocrinology, pulmonology, gastroenterology, and dermatology for treating infectious diseases, cancer, asthma, chronic obstructive pulmonary disease, atopic dermatitis, chronic rhinosinusitis with nasal polyps, inflammatory bowel disease, allergic disease, inflammatory disease, respiratory inflammation or fibrosis, cardiovascular diseases, gout, obesity, neurological conditions, and Sjögren's syndrome, all of the aforesaid developed using artificial intelligence technology
- Class 009 — Scientific and electric apparatus: Downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity in connection with pharmaceutical drug discovery and development; downloadable artificial intelligence software for use in the field of healthcare for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity
- Class 042 — Scientific and technological services: Providing online non-downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction; providing online non-downloadable self-learning and artificial intelligence software for use in the field of healthcare for pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable software using artificial intelligence for use in the biotechnology field for discovering and designing biomolecules
Owner
- Generate Biomedicines, Inc., Somerville, MA, US
Prosecution history
- 08 Jan 2026 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 03 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Sept 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Sept 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Jul 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 01 Feb 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 05 Jul 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 05 Jul 2024 — LETTER OF SUSPENSION E-MAILED
- 05 Jul 2024 — SUSPENSION LETTER WRITTEN
- 03 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Apr 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED